Fintel reports that on March 10, 2026, Jones Trading upgraded their outlook for Editas Medicine (NasdaqGS:EDIT) from Hold to Buy.
Analyst Price Forecast Suggests 100.70% Upside
As of February 25, 2026, the average one-year price target for Editas Medicine is $5.32/share. The forecasts range from a low of $1.01 to a high of $13.65. The average price target represents an increase of 100.70% from its latest reported closing price of $2.65 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Editas Medicine is 42MM, an increase of 2.97%. The projected annual non-GAAP EPS is -3.15.
What is the Fund Sentiment?
There are 236 funds or institutions reporting positions in Editas Medicine. This is an decrease of 92 owner(s) or 28.05% in the last quarter. Average portfolio weight of all funds dedicated to EDIT is 0.00%, an increase of 72.48%. Total shares owned by institutions increased in the last three months by 4.13% to 52,758K shares. 
The put/call ratio of EDIT is 0.20, indicating a bullish outlook.
What are Other Shareholders Doing?
Renaissance Technologies holds 3,040K shares representing 3.11% ownership of the company. In its prior filing, the firm reported owning 1,277K shares , representing an increase of 57.98%.
Geode Capital Management holds 2,285K shares representing 2.34% ownership of the company. In its prior filing, the firm reported owning 2,040K shares , representing an increase of 10.70%. The firm decreased its portfolio allocation in EDIT by 65.89% over the last quarter.
Nuveen holds 1,977K shares representing 2.03% ownership of the company. In its prior filing, the firm reported owning 2,092K shares , representing a decrease of 5.80%. The firm decreased its portfolio allocation in EDIT by 7.38% over the last quarter.
Two Sigma Investments holds 1,633K shares representing 1.67% ownership of the company. In its prior filing, the firm reported owning 1,584K shares , representing an increase of 2.97%. The firm decreased its portfolio allocation in EDIT by 42.31% over the last quarter.
TISEX - TIAA-CREF Quant Small-Cap Equity Fund Institutional Class holds 1,627K shares representing 1.67% ownership of the company. In its prior filing, the firm reported owning 780K shares , representing an increase of 52.08%. The firm decreased its portfolio allocation in EDIT by 9.93% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
